HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holm, L.-E. Search for Related Content PubMed PubMed Citation Articles by Holm, L.-E.

Changing Annual Incidence of Hypothyroidism after Iodine-131 Therapy for Hyperthyroidism, 1951–1975

Karolinska Hospital, Stockholm, Sweden

Correspondence: For reprints contact: L.-E. Holm, Dept. of General Oncology, Radiumhemmet, Karolinska Hospital, S-104 01 Stockholm, Sweden.

ABSTRACT

The Incidence of hypothyroidism was analyzed in 4,553 hyperthyroid patients treated with I-131 between 1951 and 1975. The average annual rate of hypothyroidism during the first 7 yr after therapy increased continuously for each 5-yr period of treatment, from 3.6% for patients treated between 1951 and 1955 to 7.7% for patients treated during the period from 1971 through 1975 (p<0.001). The increase in the incidence of hypothyroidism was seen before the introduction of TSH assays and when allowance was made for thyroid gland size, the age of the patient, and the experience of the radiotherapist. The use of TSH assays has probably resulted in an earlier recognition of hypothyroidism, which may explain why the most marked rise in the incidence of hypothyroidism was observed after the introduction of TSH assays.

This article has been cited by other articles:

				F Azizi, L Ataie, M Hedayati, Y Mehrabi, and F Sheikholeslami Effect of long-term continuous methimazole treatment of hyperthyroidism: comparison with radioiodine Eur. J. Endocrinol., May 1, 2005; 152(5): 695 - 701. [Abstract] [Full Text] [PDF]

				H. Jonsson and S. Mattsson Excess radiation absorbed doses from non-optimised radioiodine treatment of hyperthyroidism Radiat Prot Dosimetry, January 15, 2004; 108(2): 107 - 114. [Abstract] [Full Text] [PDF]